Spironolactone as a single agent for long‐term therapy of hirsute patients

@article{Spritzer2000SpironolactoneAA,
  title={Spironolactone as a single agent for long‐term therapy of hirsute patients},
  author={Poli Mara Spritzer and Kurtz Lisboa and Simone S Mattiello and Francisco Lhullier},
  journal={Clinical Endocrinology},
  year={2000},
  volume={52}
}
To assess the androgen‐suppressing effect of spironolactone, and the use of this drug as a single agent in the long‐term therapy of hirsute patients with either polycystic ovary syndrome (PCOS) or idiopathic hirsutism (IH). Standard cyproterone acetate (CPA) treatment was used to evaluate the results obtained with spironolactone. 
Spironolactone in dermatology: uses in acne and beyond
TLDR
Treatment with spironolactone aims to attenuate androgen‐mediated conditions including acne, hidradenitis suppurativa, female pattern hair loss and hirsutism. Expand
Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome
TLDR
This work aimed to determine the effects of ethinyl estradiol/drospirenone plus spironolactone therapy on inflammation and cardiometabolic risk in PCOS. Expand
Cost-effective therapy in patients with idiopathic hirsutism
TLDR
This review analyses the causes of hirsutism and provides information on each therapy and the cost-effective results in patients with idiopathic hirsUTism. Expand
Spironolactone for Hirsutism in Polycystic Ovary Syndrome
TLDR
The outcomes reported to date have shown a positive trend toward using spironolactone in women with PCOS and hirsutism. Expand
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: A randomised controlled study
TLDR
Flutamide and spironolactone plus CPA/EE are effective drugs in the treatment of hirsutism and total cholesterol levels decreased significantly but no significant change was observed in any other lipid parameters or in the patients’ hormone profiles. Expand
A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism
TLDR
In most patients, low doses of antiandrogens (cyproterone acetate, flutamide or spironolactone) are used with few adverse effects and good results in terms of improvement of the hirsutism. Expand
Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
TLDR
The combination of low-dose spironolactone with metformin seems superior to either drug alone in terms of clinical benefits and compliance in women with PCOS. Expand
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
TLDR
Both therapies have similar effectiveness in the treatment of idiopathic hirsutism, and no major side effect, including liver toxicity, was observed in either group. Expand
Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.
TLDR
Both drugs are effective in the management of PCOS and spironolactone appears better than metformin in the treatment of hirsutism, menstrual cycle frequency, and hormonal derangement and is associated with fewer adverse events. Expand
Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
  • H. Diri, S. Karaburgu, +4 authors F. Kelestimur
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2016
TLDR
FGSs were significantly decreased in both groups; however, combination therapy was not more effective than spironolactone alone in terms of BMI, FGS, hormone levels, or insulin resistance. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
A novel use of spironolactone: treatment of hirsutism.
TLDR
The data suggest that the antiandrogenic properties of spironolactone render it a suitable agent in the treatment of hirsutism. Expand
Cyproterone acetate for severe hirsutism:results of a double‐blind dose‐ranging study *
TLDR
The objective was to determine If cyproterone acetate (CPA) therapy lor hirsute women demonstrated a dose response and to establish a protocol for evaluating this response. Expand
THE TREATMENT OF HIRSUTISM: EXPERIENCE WITH CYPROTERONE ACETATE AND SPIRONOLACTONE
TLDR
These drugs should not be used in patients without adequate contraception because of the risk to the foetus, and further evaluation of the relative merits of the two drugs is required. Expand
A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
TLDR
Finasteride and spironolactone treatment resulted in a similar clinical effect on hirsutism, and further studies with finasteride are needed to verify its effectiveness as a treatment for hirsUTism. Expand
Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
TLDR
Following termination of the medication, the various symptoms of virilism reappeared more or less quickly and markedly in the majority of the patients unless they are placed on oral contraceptives containing a derivative of 17-acetoxyprogesterone. Expand
Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
TLDR
The present data obtained in a randomized prospective study clearly demonstrate that the pure antiandrogen flutamide is superior to spironolactone in the treatment of female hirsutism and its related androgen-dependent symptoms and signs in women. Expand
USE OF CYPROTERONE ACETATE (CPA) IN THE TREATMENT OF ACNE, HIRSUTISM AND VIRILISM
TLDR
Following termination of the medication, the various symptoms of virilism reappeared more or less quickly and markedly in the majority of the patients unless they are placed on oral contraceptives containing a derivative of 17-acetoxyprogesterone. Expand
Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
TLDR
Both spironolactone and CPA were similarly effective in treatment of hirsutism, and a trend toward a better response with CPA treatment, which did not achieve significance. Expand
Treatment of hirsutism with spironolactone.
  • R. Tremblay
  • Medicine
  • Clinics in endocrinology and metabolism
  • 1986
TLDR
It is concluded that spironolactone is an effective drug in the treatment of female hirsutism on the basis of the data and the clinical experience. Expand
Treatment of hirsutism with spironolactone.
TLDR
Spironolactone is a highly effective and safe agent for the treatment of hirsutism through its inhibitory action on both ovarian androgen secretion and peripheral androgen action. Expand
...
1
2
3
4
5
...